COVID-19 Vaccine Effect, Response and Safety (COVERS) Sweden: clinical and epidemiological studies with special focus on vulnerable groups | Pandemic PACT Tracker

Key facts

Disease
COVID-19
Known Financial Commitments (USD)
$1,803,000
Principal Investigator
Class Ahlm
Research Location
Sweden
Lead Research Institution
N/A
Research Priority Alignment
N/A

Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Immunity
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified

Abstract

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Barriers and motivators associated with COVID-19 vaccination-a vaccine acceptance scoring system based on a population survey in southern Sweden.

Anti-SARS-CoV-2 nucleocapsid antibodies to detect exposure to SARS-CoV-2: results from a prospective cohort study on COVID-19 vaccination.

Sociodemographic differences in the response to changes in COVID-19 testing guidelines.

Cause-specific excess mortality in Denmark, Finland, Norway, and Sweden during the COVID-19 pandemic 2020-2022: a study using nationwide population data.

Excess mortality in Denmark, Finland, Norway and Sweden during the COVID-19 pandemic 2020-2022.

Age and sex differences in cause-specific excess mortality and years of life lost associated with COVID-19 infection in the Swedish population.

Waning protection after vaccination and prior infection against COVID-19-related mortality over 18 months.

A regression discontinuity analysis of the social distancing recommendations for older adults in Sweden during COVID-19.

Surveillance of COVID-19 vaccine effectiveness - a real-time case-control study in southern Sweden.